Amsterdam UMC Clinical Trial With a Native-like HIV-1 Envelope Vaccine

NCT03961438 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

BIOLOGICAL: ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
BIOLOGICAL: ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)